Abstract Competition Winners
First Place
Abstract #1 – University of Chicago School of Medicine (Multi-Institutional Clinical Trial)
Title: Safety and Feasibility of Intraprostatic Injection of CAN-2409 or Placebo followed by Valacyclovir in Patients on Active Surveillance for Prostate Cancer (ULYSSES Trial)
Submitted by: Scott Eggener, MD, University of Chicago School of Medicine
Second Place (Tied)
Abstract #7 – Washington University School of Medicine in St. Louis, Leeds Teaching Hospitals NHS Trust and Blue Earth Diagnostics
Title: Impact of 18F-Fluciclovine PET/CT on Plans for ADT in Patients with Biochemical Recurrence of Prostate Cancer; Analysis from Two Prospective Clinical Trials
Submitted by: Gerald Andriole, MD, Washington University School of Medicine
Abstract #14 – Cleveland Diagnostics
Title: IsoPSA®: Clinical Performance of a Single Parameter, Structure Based Test for High Grade Prostate Cancer in a Large, Multicenter, Prospective Validation Trial
Submitted by: Mark Stovsky, MD, Chief Medical Officer
Third Place
Abstract #16 – Lantheus Medical Imaging
Title: OSPREY and CONDOR: Results from Two Registrational Clinical Studies Assessing the Diagnostic Performance of Piflufolastat F 18 (PYLARIFY®) PET/CT in Patients with High-Risk and Recurrent Prostate Cancer
Submitted by: Bela Denes, MD
ABSTRACT REVIEW COMMITTEE
Sigrid Carlsson, MD, PhD, MPH
Assistant Attending Epidemiologist, Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center and Associate Professor of Experimental Urology, Sahlgrenska Academy, Gothenburg University, Sweden
E. David Crawford, MD
Professor of Urology, University of California San Diego; Chairman, Prostate Conditions Education Council; Editor in Chief, Grand Rounds in Urology; and Prostate Cancer Series Editor, Oncology Journal
Andrei Iagaru, MD, FACNM
Professor of Radiology – Nuclear Medicine Chief, Division of Nuclear Medicine and Molecular Imaging Co-Director, PET-MRI Research Program Stanford University
Kelvin A. Moses, MD, PhD, FACS
Associate Professor of Urology and Director of Comprehensive Prostate Cancer Clinic, Vanderbilt University Medical Center, and Member, NCCN Prostate Cancer Early Detection Guidelines Panel
Daniel Petrylak, MD
Professor of Medicine, Director of Genitourinary Oncology and Co-Director of Signal Transduction Program, Yale University
Sanoj Punnen, MD, MAS
Co-Chair of Genitourinary Site Disease Group, Pap Corps Champions for Cancer Research Endowed Chair in Solid Tumor Research and
Associate Professor, Department of Urology, University of Miami, Miller School of Medicine
Grannum Sant, MD, FRCS, FACS
Professor and Former Chair of Urology, Tufts University School of Medicine; Former Head, Oncology/Urology Medical Affairs, Sanofi, and Rare Genetic Diseases, Genzyme
Daniel Y. Song, MD
Professor of Radiation Oncology and Molecular Radiation Sciences, and Co-Director, Prostate Cancer Multi-Disciplinary Clinic, Johns Hopkins University
Wolfgang Weber, MD
Professor and Chair, Department of Nuclear Medicine, Klinikum der Isar, Technical University of Munich, Germany
Jeffrey Weinreb, MD, FACR, FISMRM, FSABI
Professor, Department of Diagnostic Radiology and Biomedical Imaging, Yale School of Medicine and Chief of MRI Services, Yale-New Haven Hospital
